WASHINGTON, March 7 -- The Senate Special Committee on Aging released the following written testimony by Jeremy D. Schmahmann, founding director of the Massachusetts General Hospital Ataxia Center, Boston, and a professor of neurology at Harvard Medical School, from a Feb. 26, 2026, hearing entitled "From Regulator to Roadblock: How FDA Bureaucracy Stifles Innovation." FDA is the Food and Drug Administration.

* * *

Chairman Scott, Ranking Member Gillibrand, Me . . .

Click here for more information about our products